{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:11:32Z","timestamp":1775841092155,"version":"3.50.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T00:00:00Z","timestamp":1364947200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0059676","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T03:28:04Z","timestamp":1365046084000},"page":"e59676","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":60,"title":["Genetic Loci Associated with Alzheimer\u2019s Disease and Cerebrospinal Fluid Biomarkers in a Finnish Case-Control Cohort"],"prefix":"10.1371","volume":"8","author":[{"given":"Lyzel S.","family":"Elias-Sonnenschein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seppo","family":"Helisalmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu","family":"Natunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu","family":"Paajanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanna-Kaisa","family":"Herukka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjo","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Remes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Koivisto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari M.","family":"Mattila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terho","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans R. J.","family":"Verhey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter Jelle","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilkka","family":"Soininen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko","family":"Hiltunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,4,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"K Blennow","year":"2006","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy","volume":"10","author":"G Bu","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ajmg.b.32094","article-title":"Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer\u2019s disease","volume":"159B","author":"LM Bekris","year":"2012","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Cruchaga C, Kauwe JS, Mayo K, Spiegel N, Bertelsen S, et al.. (2010) SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer\u2019s disease. PLoS Genet 6.","DOI":"10.1371\/journal.pgen.1001101"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tins.2008.11.007","article-title":"Tau pathophysiology in neurodegeneration: a tangled issue","volume":"32","author":"TL Spires-Jones","year":"2009","journal-title":"Trends Neurosci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans","volume":"59","author":"AM Fagan","year":"2006","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.gde.2011.02.002","article-title":"Genetics of Alzheimer\u2019s disease: new evidences for an old hypothesis?","volume":"21","author":"JC Lambert","year":"2011","journal-title":"Curr Opin Genet Dev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","article-title":"The genetics of Alzheimer disease: back to the future","volume":"68","author":"L Bertram","year":"2010","journal-title":"Neuron"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2217\/bmm.12.56","article-title":"Relationship between genetic risk factors and markers for Alzheimer\u2019s disease pathology","volume":"6","author":"LS Elias-Sonnenschein","year":"2012","journal-title":"Biomark Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"L Bertram","year":"2007","journal-title":"Nat Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"WJ Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"LA Farrer","year":"1997","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Schellenberg GD, Montine TJ (2012) The genetics and neuropathology of Alzheimer\u2019s disease. Acta Neuropathol.","DOI":"10.1007\/s00401-012-0996-2"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"832379","DOI":"10.4061\/2011\/832379","article-title":"Genetics of late-onset Alzheimer\u2019s disease: update from the alzgene database and analysis of shared pathways","volume":"2011","author":"P Olgiati","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease","volume":"43","author":"P Hollingworth","year":"2011","journal-title":"Nat Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"S Seshadri","year":"2010","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease","volume":"43","author":"AC Naj","year":"2011","journal-title":"Nat Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2377-10-90","article-title":"Genome-wide association reveals genetic effects on human Abeta42 and tau protein levels in cerebrospinal fluids: a case control study","volume":"10","author":"MR Han","year":"2010","journal-title":"BMC Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.0b013e318204a397","article-title":"Genome-wide association study of CSF biomarkers Abeta1\u201342, t-tau, and p-tau181p in the ADNI cohort","volume":"76","author":"S Kim","year":"2011","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.neurobiolaging.2010.01.010","article-title":"Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study","volume":"32","author":"PL Kramer","year":"2011","journal-title":"Neurobiol Aging"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/01.WNL.0000118208.16939.60","article-title":"Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease","volume":"62","author":"S Iivonen","year":"2004","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10048-008-0150-4","article-title":"Alzheimer\u2019s disease risk variants show association with cerebrospinal fluid amyloid beta","volume":"10","author":"JS Kauwe","year":"2009","journal-title":"Neurogenetics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/jnnp.2005.071928","article-title":"Association of CYP46 intron 2 polymorphism in Finnish Alzheimer\u2019s disease samples and a global scale summary","volume":"77","author":"S Helisalmi","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00439-004-1107-9","article-title":"Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer\u2019s disease","volume":"114","author":"A Johansson","year":"2004","journal-title":"Hum Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/jnnp.2008.160002","article-title":"Combined risk effects of IDE and NEP gene variants on Alzheimer disease","volume":"80","author":"S Vepsalainen","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/jmg.2006.048470","article-title":"Insulin-degrading enzyme is genetically associated with Alzheimer\u2019s disease in the Finnish population","volume":"44","author":"S Vepsalainen","year":"2007","journal-title":"J Med Genet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.neurobiolaging.2004.07.011","article-title":"Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer\u2019s disease brain","volume":"26","author":"ME Blomqvist","year":"2005","journal-title":"Neurobiol Aging"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"JC Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Lambert JC, Zelenika D, Hiltunen M, Chouraki V, Combarros O, et al.. (2011) Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging 32: 756 e711\u2013755.","DOI":"10.1016\/j.neurobiolaging.2010.11.022"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00415-005-0667-5","article-title":"Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer\u2019s disease","volume":"252","author":"S Vepsalainen","year":"2005","journal-title":"J Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bioinformatics\/19.1.149","article-title":"Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits","volume":"19","author":"S Purcell","year":"2003","journal-title":"Bioinformatics"},{"key":"ref33","unstructured":"Lenth RV (2006\u20139) Java Applets for Power and Sample Size."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society, Series B"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d","volume":"12","author":"MF Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Jun G, Vardarajan BN, Buros J, Yu CE, Hawk MV, et al.. (2012) Comprehensive Search for Alzheimer Disease Susceptibility Loci in the APOE Region. Arch Neurol: 1\u201310.","DOI":"10.1001\/archneurol.2012.2052"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3233\/JAD-2010-091711","article-title":"Validating predicted biological effects of Alzheimer\u2019s disease associated SNPs using CSF biomarker levels","volume":"21","author":"JS Kauwe","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"ref38","unstructured":"Schott JM (2011) Using CSF biomarkers to replicate genetic associations in Alzheimer\u2019s disease. Neurobiol Aging."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archgenpsychiatry.2010.196","article-title":"The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels","volume":"68","author":"BM Schjeide","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"ref40","first-page":"191","article-title":"Beta-Amyloid Toxicity Modifier Genes and the Risk of Alzheimer\u2019s Disease","volume":"1","author":"SL Rosenthal","year":"2012","journal-title":"Am J Neurodegener Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000336790","article-title":"Alzheimer\u2019s disease: genetic polymorphisms and rate of decline","volume":"33","author":"C Schmidt","year":"2012","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Karch CM, Jeng AT, Goate AM (2012) Calcium phosphatase calcineurin influences tau metabolism. Neurobiol Aging.","DOI":"10.1016\/j.neurobiolaging.2012.05.003"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/157015911798376316","article-title":"A role for calcineurin in Alzheimer\u2019s disease","volume":"9","author":"LC Reese","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archneurol.2010.346","article-title":"Meta-analysis of the association between variants in SORL1 and Alzheimer disease","volume":"68","author":"C Reitz","year":"2011","journal-title":"Arch Neurol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000332017","article-title":"Impact of SORL1 single nucleotide polymorphisms on Alzheimer\u2019s disease cerebrospinal fluid markers","volume":"32","author":"P Alexopoulos","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2008.05.049","article-title":"Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer\u2019s disease","volume":"440","author":"H Kolsch","year":"2008","journal-title":"Neurosci Lett"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/156720512800492431","article-title":"Association of SORL1 alleles with late-onset Alzheimer\u2019s disease. findings from the GIGAS_LOAD study and mega-analysis","volume":"9","author":"P Olgiati","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archneur.65.12.1640","article-title":"Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease","volume":"65","author":"KT Cuenco","year":"2008","journal-title":"Arch Neurol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1073\/pnas.0801227105","article-title":"Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition","volume":"105","author":"JS Kauwe","year":"2008","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0059676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T03:08:23Z","timestamp":1745982503000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0059676"}},"subtitle":[],"editor":[{"given":"Patrick","family":"Lewis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,3]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0059676","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,3]]}}}